# SERTRALINE HYDROCHLORIDE

NDC: 50228-467
Generic name: SERTRALINE HYDROCHLORIDE
Labeler / Manufacturer: ScieGen Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230508

FDA application: ANDA076442

## Active ingredients

- SERTRALINE HYDROCHLORIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-467"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-467
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10b9cae4-b452-4abb-866a-9f9d2568f212